title: New treatment options in the management of IBD - focus on colony stimulating factors.
abstract: Inflammatory bowel disease (IBD) is characterized by inflammation of the gastrointestinal tract, typically with a relapsing and remitting clinical course. The intestinal inflammation in IBD is controlled by a complex interplay of innate and adaptive immune mechanisms. Innate immunity comprises a set of distinct elements, which includes circulating cells such as neutrophils, monocytes, and resident intestinal immune cells (dendritic and Paneth cells), as well as intestinal epithelium and cellular products, including antimicrobial peptides such as defensins and cathelicidins. Different components of innate immunity in IBD have been suggested to be defective or impaired. The human granulocyte-macrophage colony-stimulating factor (GM-CSF) and the human granulocyte colony-stimulating factor (G-CSF) have emerged as potential tools for the modulation of intestinal inflammation and repair. The greatest evidence supporting the use of colony-stimulating factors in intestinal inflammation comes from studies conducted in active Crohn's disease (CD) patients treated with sargramostim and filgrastim, but evidence for its recommendation as treatment remains weak, as the majority of studies are open label, nonrandomized, and with a small number of patients.
authors.affiliation: Inflammatory Bowel Disease Clinic, Department of Gastroenterology, Instituto Nacional de Ciencias, Médicas y Nutrición "Salvador Zubirán", Mexico City, Mexico.
authors.forename: Josué
authors.initials: J
authors.lastname: Barahona-Garrido
authors.forename: Jesús K
authors.initials: JK
authors.lastname: Yamamoto-Furusho
references.citation: Inflamm Bowel Dis. 2008 Oct;14(10):1443-52
references.pmid: 18421761
references.citation: Ann N Y Acad Sci. 2006 Aug;1072:300-6
references.pmid: 17057209
references.citation: Gut. 2008 Jul;57(7):903-10
references.pmid: 18305068
references.citation: J Leukoc Biol. 2006 Apr;79(4):860-6
references.pmid: 16461743
references.citation: J Immunol. 2005 May 15;174(10):6518-23
references.pmid: 15879155
references.citation: J Clin Gastroenterol. 1997 Jun;24(4):253-6
references.pmid: 9252852
references.citation: J Interferon Cytokine Res. 2006 May;26(5):291-300
references.pmid: 16689657
references.citation: Lancet. 2002 Nov 9;360(9344):1478-80
references.pmid: 12433518
references.citation: Clin Exp Immunol. 1996 Dec;106(3):529-33
references.pmid: 8973623
references.citation: Dan Med Bull. 1986 Oct;33(5):222-8
references.pmid: 3536336
references.citation: Lancet. 2006 Feb 25;367(9511):668-78
references.pmid: 16503465
references.citation: Aliment Pharmacol Ther. 2006 Aug 15;24(4):651-60
references.pmid: 16907898
references.citation: World J Gastroenterol. 2006 Nov 14;12(42):6751-5
references.pmid: 17106921
references.citation: Gastroenterology. 1976 Mar;70(3):439-44
references.pmid: 1248701
references.citation: Gut. 2004 Nov;53(11):1658-64
references.pmid: 15479689
references.citation: N Engl J Med. 1992 Jun 18;326(25):1666-9
references.pmid: 1375344
references.citation: J Pathol. 2008 Jan;214(2):260-6
references.pmid: 18161747
references.citation: Gut. 1998 Jan;42(1):127-30
references.pmid: 9505898
references.citation: Inflamm Bowel Dis. 2008 Aug;14(8):1033-40
references.pmid: 18383179
references.citation: Lancet. 2005 May 21-27;365(9473):1794-6
references.pmid: 15910952
references.citation: J Gastroenterol Hepatol. 1999 Jan;14(1):46-53
references.pmid: 10029277
references.citation: Digestion. 2003;68(2-3):63-70
references.pmid: 14581762
references.citation: Gut. 1991 Apr;32(4):399-402
references.pmid: 1851125
references.citation: Lancet. 1976 Jul 31;2(7979):219-21
references.pmid: 59239
references.citation: Aliment Pharmacol Ther. 2005 Feb 15;21(4):391-400
references.pmid: 15709989
references.citation: N Engl J Med. 2005 May 26;352(21):2193-201
references.pmid: 15917384
references.citation: Eur J Gastroenterol Hepatol. 2003 Jun;15(6):627-34
references.pmid: 12840673
references.citation: Inflamm Bowel Dis. 2008 Jan;14(1):88-99
references.pmid: 17932977
references.citation: Scand J Gastroenterol. 1985 Nov;20(9):1151-6
references.pmid: 4089525